Skip to main content
. 2019 Jun 2;16(6):813–821. doi: 10.7150/ijms.32599

Table 2B.

AT2 receptor expression in CRC tissues (n=161) according to pathological variables

Variables Weak (%) Strong (%) Total (n) P value
Histologic Subtype
AdC 28.3 71.7 145 0.2
MuC 43.8 56.2 16
Histologic Grade
G1 50 50 6 0.1
G2 26.5 73.5 136
G3 47.4 52.6 19
Local Invasion (pT)
pT2 26.2 73.8 42 0.002(a)
pT3 25.7 74.3 105
pT4 71.4 28.6 14
Affected Lymph Nodes (N)
N0 26.3 73.7 95 0.1(b)
N1 29.4 70.6 51
N2 53.3 46.7 15
Stage (TNM system)
I 26.5 73.5 34 0.16(c)
II 25 75 60
III 33.3 66.7 63
IV 75 25 4
Vascular Invasion (V)
No 27 73 141 0.035
Yes 50 50 20
Lymphatic Invasion (L)
No 27.1 72.9 133 0.097
Yes 42.9 57.1 28
Perineural Invasion (Pn)
No 28.1 71.9 139 0.22
Yes 40.9 59.1 22

(a) AT2 expression was higher in pT2 (p=0.002) and pT3 (p=0.001) than in pT4 CRCs.

(b) Differences were found between N0 and N2 CRCs (p=0.03).

(c) Stage IV CRCs showed lower AT1 staining than Stage I (p=0.04) and II (p=0.03) ones.